Baric Transcribed Interview (Redacted) — page 104

DC.Scheduling@LexitasLegal.com experiments was to take the virus that had the furin cleavage site in it, resurrect that virus, put it in animals, see what the effect was. Remove the furin cleavage site, see what the effect was. If the furin cleavage site is driving a massive disease phenotype, then that results in a judgment question about whether you would do the next experiment. And it also would then demand the importance of having it reviewed before you proceeded. MS. SALAZAR: Okay. DR. BARIC: Before you proceed. MS. SALAZAR: So are you saying that we can never say whether a grant proposal was proposing to do gain-of13 function until we get all the way up to the point where you actually almost do it? DR. BARIC: No. I'm saying in the context of a grant proposal where the agency asks you specifically to learn, down to the nucleotide level, what causes the phenotype, yes, you do all those experiments. MS. SALAZAR: Okay. So are you saying that all of the other entities that were awarded grants -- DR. BARIC: I have no idea what they were awarded. All that I know is that we were not awarded. MS. SALAZAR: Okay. I mean, you were not awarded, but there was discussion post the denial about doing a smaller proposal, separating it out.